] cyt ; also, it does not explain the presence of multiple, functionally distinct isoforms of the Na ϩ pump in many cells. We investigated the effects of Na ϩ pump inhibition on [Na ϩ ] cyt (with Na ϩ binding benzofuran isophthalate) and Ca 2ϩ transients (with fura 2) in primary cultured arterial myocytes. Low concentrations of ouabain (3-100 nM) or human ouabain-like compound or reduced extracellular K ϩ augmented hormoneevoked mobilization of stored Ca 2ϩ but did not increase bulk [Na ϩ ] cyt . Augmentation depended directly on external Na ϩ , but not external Ca 2ϩ , and was inhibited by 10 mM Mg 2ϩ or 10 M La 3ϩ . Evoked Ca 2ϩ transients in pressurized small resistance arteries were also augmented by nanomolar ouabain and inhibited by Mg 2ϩ . These results suggest that Na ϩ enters a tiny cytosolic space between the plasmalemma (PL) and the adjacent sarcoplasmic reticulum (SR) via an Mg 2ϩ -and La 3ϩ -blockable mechanism that is activated by SR store depletion. The Na ϩ and Ca 2ϩ concentrations within this space may be controlled by clusters of high ouabain affinity (␣3) Na ϩ pumps and Na/Ca exchangers located in PL microdomains overlying the SR. Inhibition of the ␣3 pumps by low-dose ouabain should raise the local concentrations of Na ϩ and Ca 2ϩ and augment hormone-evoked release of Ca 2ϩ from SR stores. Thus the clustering of small numbers of specific PL ion transporters adjacent to the SR can regulate global Ca 2ϩ signaling. This mechanism may affect vascular tone and blood flow and may also influence Ca 2ϩ signaling in many other types of cells.
vasoconstrictors; sodium pump; sodium/calcium exchange; junctional sarcoplasmic reticulum SODIUM PUMPS IN THE PLASMALEMMA (PL) of animal cells maintain a low cytosolic Na ϩ concentration ([Na ϩ ] cyt ) (16) . 1 These pumps also are receptors for exogenous cardiotonic steroids (CTS) such as ouabain (16, 44) as well as for an endogenous ouabain-like compound (OLC) (19) . Four different Na ϩ pump catalytic (␣) subunit isoforms (␣1-␣4) have been recognized. Each is the product of a different gene and, in the rat, can be distinguished by its affinity for ouabain and for [Na ϩ ] cyt (5, 46) . Most cells in the rat express the high Na ϩ /low ouabain affinity isoform (␣1) as well as one or more of the independently regulated low Na ϩ /high ouabain affinity isoforms (␣2, ␣3, or ␣4) (5, 26, 46) . Moreover, the different isoforms are differently distributed in the cells. For example, the ␣1-isoform is distributed uniformly in the PL of neurons, astrocytes, and mesenteric arterial myocytes (26) . In contrast, the ␣3-and ␣2-isoforms, which are also present in neurons and arterial myocytes and in astrocytes, respectively, appear to be confined to PL microdomains adjacent to peripheral or "junctional" (j) elements of the sarco/endoplasmic reticulum (S/ER; jS/ER) (26) . Despite the differences in their properties and localization, the functional significance of these isoforms has been unclear.
It is generally believed that CTS exert their effects by inhibiting Na ϩ pumps, elevating bulk [Na ϩ ] cyt , and, in turn, raising cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] cyt ) via Na/Ca exchange (3, 6, 28) . Most of the entering Ca 2ϩ is rapidly sequestered in the S/ER (6, 28) , and this permits additional Ca 2ϩ to be mobilized when the cells are activated (50) . These steps have all been verified with relatively high ouabain concentrations, usually 1-1,000 M (6, 31) . A longstanding enigma, however, is that nanomolar (therapeutic) concentrations of CTS augment cardiac (31) and arterial (48) contractions, induce hypertension in rats (34) , and have other effects, despite little or no change in whole cell ("bulk") [Na ϩ ] cyt (31) or resting [Ca 2ϩ ] cyt (51) . Such findings are incompatible with the generally accepted view of CTS action mentioned above. Furthermore, this view of CTS action does not account for the coexpression of multiple Na ϩ pump ␣-subunit isoforms with different kinetic properties including different affinities for ouabain.
Recently, isoforms of the Na ϩ pump with high affinity for ouabain were shown to cluster with Na/Ca exchangers in PL microdomains of rat arterial smooth muscle cells (27) and some other cell types (21, 27, 30, 36 Coverslips, mounted in a 1-ml chamber on the stage of an inverted fluorescence microscope, were superfused [32°C, 5 ml/min; chamber washout half-time (t 1/2 ) Ϸ30 s] with physiological salt solution (PSS). Normal PSS contained (in mM) 140 NaCl, 5.0 KCl, 1.2 NaH 2 PO 4 , 5 NaHCO 3 , 1.4 MgCl 2 , 1.8 CaCl 2 , 11.5 glucose, and 10 mM HEPES (titrated to pH 7.4 with NaOH). For the first 40 min, cells were superfused with PSS to remove extracellular dye and to permit the intracellular esterases to cleave the fura 2-AM or SBFI-AM. CaCl 2 was omitted from Ca-free ("0" Ca) PSS, and 0.2 mM EGTA was added; 0 Ca-5 Na ϩ PSS contained 5 mM NaCl and 140 mM N-methyl-D-glucamine. In low K ϩ PSS, Na ϩ replaced K ϩ . NaH 2 PO 4 and NaHCO 3 were both omitted from PSS containing LaCl 3 . Solution osmolarity was adjusted to 320 mosM with sucrose. The cells were routinely activated with low agonist concentrations (ϽEC 50 ; see RESULTS) to avoid saturation of the agonist receptors or the fura 2. Arginine vasopressin (AVP) was from Peninsula Labs (Belmont, CA ] cyt were determined with digital ratiometric imaging (9, 17) : fura 2 excitation ϭ 360 and 380 nm, emission ϭ 510 nm; SBFI excitation ϭ 340 and 380 nm, emission ϭ 510 nm. A ϫ40 1.3-NA Nikon UV Fluor oil immersion objective was used for imaging. Fields containing 5-8 cells were imaged, background-subtracted, and transformed to [Ca 2ϩ ] or [Na ϩ ] images (MetaFluor; Universal Imaging, West Chester, PA). Fluorescence ratio data for each cell were obtained from a 5 ϫ 5-pixel (1.5 ϫ 1.5-m) nonnuclear region (1/cell). To enhance the signal-to-noise ratio, 32 frames were averaged at video frame rate, except when agonists and/or ouabain were added; then only four frames were averaged to improve temporal resolution. Images were acquired at a rate of two per minute, except during agonist application, when the rate was increased to two per second.
Isolated small mesenteric arteries. Sprague-Dawley male rats, 200-400 g, were anesthetized and decapitated, and small resistance arteries (length ϭ 3-4 mm, maximum passive diameter ϭ 200-220 m; see Experimental protocol for blood vessels) were isolated (35) . The arteries were dissected at 5-6°C in a "dissection solution" of the following composition (in mM): 145 NaCl, 5 KCl, 2.5 CaCl 2 , 1 MgSO 4 , 1 KH 2 PO 4 , 2 pyruvate, and 5 glucose, with 1% bovine serum albumin (pH ϭ 7.4, osmolarity ϭ 310-320 mosM). The vessels were denuded of endothelium by perfusion of the lumen (through a small pipette) with tiny air bubbles for 30 s. Removal of the endothelium was verified by the abolition of a 2 M acetylcholine-evoked Ca 2ϩ transient or vasodilation. The arteries were placed in a 2-ml experimental chamber on the microscope stage, and the open ends were mounted on glass cannulas. One cannula was sealed off, and the artery was pressurized to 70 mmHg.
Experimental protocol for blood vessels. Resistance arteries were superfused (2.5 ml/min, 37°C) with modified Krebs solution of the following composition (in mM): 115 NaCl, 4.7 KCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , 10 glucose, and 1.8 HEPES (pH ϭ 7.4, osmolarity ϭ 310-320 mosM, bubbled with 95% air-5% CO 2 ); the solution also contained 5 M guanethidine to deplete catecholamines from the nerve terminals. Before the experiments were started, the vessels were incubated for 1 h; maximum passive diameter was then determined by a 20-min wash in Ca 2ϩ -free Krebs containing 2 mM EGTA. For each experimental protocol, the Krebs solution also contained 50 M tetrodotoxin during one entire experiment to verify that the responses were unaffected by the presence of this agent.
To measure intracellular Ca 2ϩ , the arteries were loaded with 5 M fura 2-AM for 3 h in dissection solution at 22-25°C in a 95% O 2 -5% CO 2 atmosphere. After dye loading, the vessel was first mounted on one of the cannulas and was internally perfused to wash out residual dye from the lumen. The other end was then cannulated so that the vessel could be pressurized. In the vessel experiments, fura 2 was excited at 380, 360 (the isosbestic point), and 340 nm, and emission was recorded at 510 nm. Because of uncertainty in the dye calibration in these arteries, the data are reported as the background (bkg)-subtracted ratios of fluorescence (F) emitted when the dye was excited at 360 and 380 nm [i.e., F 360 /F 380 ϭ (F 360 Ϫ F bkg 360 )/(F 380 Ϫ F bkg 380 ), where F bkg 360 and F bkg 380 were obtained when the artery was moved out of the field]. The F 360 values were used so that we could keep track of bleaching and minimize movement/contraction artifacts in the fluorescent signals. In each experiment, fluorescent ratio data were obtained from each of three different 5 ϫ 50-pixel (1.5 ϫ 15-M) areas of the vessel wall; these data were then averaged off-line to obtain a single value for each vessel. To improve the signal-to-noise ratio, 32 frames were averaged at video frame rate to obtain the data, except when agonists and/or ouabain were added; in these latter instances, only four frames were averaged to improve temporal resolution. Image ratios were acquired at a rate of one per minute, except during periods of agonist application when the rate was increased to one per second. When the vessels were stimulated with phenylephrine (PE), the "steady-state" F 360 /F 380 ratio was taken as the last data point before washout of PE.
Statistical analysis. Data (fluorescence ratios and calibrated values) were analyzed and plotted with Sigma Plot software (Jandel, San Rafael, CA). The significance of the differences between means (ϮSE) for the same groups of cultured cells and for small arteries under various conditions was calculated by Student's paired t-test.
RESULTS

Nanomolar ouabain amplifies evoked Ca
2ϩ transients in cultured arterial myocytes. Figure 1A illustrates the protocol and a key result. The responses to four consecutive 30-s applications of serotonin (5-HT) in PSS are shown. The first 5-HT application was a control. During the second and third exposures, ouabain (10 and 100 nM, respectively) and 5-HT were applied simultaneously. Ouabain was omitted during the fourth 5-HT application ("recovery"). The 5-HTevoked Ca 2ϩ transients were negligibly affected by 10 nM ouabain, whereas 100 nM ouabain reversibly augmented transients 1.8-fold (Fig. 1, A and B ; Table 1 contains summary data). With a 60-s preincubation to permit more complete solution exchange and equilibration (see MATERIALS AND METHODS), 100 nM ouabainaugmented 5-HT evoked Ca 2ϩ transients 2.6-fold (Fig.  1B) ; the apparent EC 50 was 8 nM, comparable with the IC 50 for block of the rat Na ϩ pump ␣3 isoform (5).
The graph in Fig. 1C shows the recovery from the ouabain-induced augmentation of the peak Ca 2ϩ transients; ouabain could be washed out with a t 1/2 of Ϸ30 s. In these experiments, the cells were incubated with 100 nM ouabain for 30 s; the ouabain was then washed out for various lengths of time (as indicated on the ordinate) before the 5-HT stimulation (Fig. 1C) . These results indicated that ouabain dissociates rapidly from its high-affinity binding sites in these myocytes. Table 1A shows summary data for the Ca 2ϩ transients evoked by 0.1 nM AVP, by 100 nM PE and 5-HT, and by 1 M cyclopiazonic acid (CPA), an inhibitor of S/ER Ca 2ϩ pumps and the augmentation of these transients by simultaneous application of 100 nM ouabain. In each case, ouabain reversibly augmented the peak transient by ϳ1.8-to 2.0-fold; thus the effect did not appear to be agonist specific. Moreover, inhibition of the Na ϩ pumps with another CTS, 100 nM digoxin (Table 1A) (Table 1B) had similar effects. Figure 2 shows that the OLC isolated from human plasma (19) also augmented the Ca 2ϩ transients. Indeed, the augmentation of 5-HT-evoked Ca 2ϩ transients by 10-30 nM human OLC and (plant) ouabain (Fig. 2, A-C) was quantitatively indistinguishable (Fig. 2C-a) . This implies that ouabain and OLC have similar potencies in these cells.
Amplification by ouabain requires external Na ϩ but does not depend on a rise in bulk [Na ϩ ] cyt . When external Ca 2ϩ was removed 30 s before 5-HT application, ouabain amplified the peak Ca 2ϩ transients evoked by 5-HT without increasing the duration of the transients ( Fig. 1D ; Table 1A ). The augmentation of the peak transients was also unaffected by 10 M nifedipine ( ] cyt did not rise under these conditions or even when 100 nM ouabain was superfused for 10 min (Fig.  3A) or [K ϩ ] O was lowered to 1 mM for 10 min (Fig. 3B) . As expected, significantly higher doses of ouabain (1-10 M) did raise [Na ϩ ] cyt (Fig. 3A) (Fig. 1F) or by inhibition of Na ϩ pump-mediated Na ϩ extrusion, with either nanomolar concentrations of ouabain (Fig. 1, A blocked both the ouabain-and the 1 mM K ϩ -induced augmentation of 5-HT-evoked Ca 2ϩ transients (Fig. 4  and Table 1, C and D) , as well as the augmentation induced by human OLC (Fig. 2C-b) Effects of ouabain on PE-evoked Ca 2ϩ transients in pressurized small arteries. The aforementioned experiments were performed on cultured myocytes from large, muscular mesenteric arteries. In small arteries and arterioles, myogenic tone plays a role in the regulation of vessel diameter and blood flow in response to changes in perfusion pressure. To determine the possible influence of ouabain on the function of these vessels, which are responsible for much of the peripheral vascular resistance, we studied evoked Ca 2ϩ transients in pressurized small mesenteric arteries. In control experiments (not shown), a 60-min exposure to nanomolar ouabain had no detectable effect on [ To eliminate Ca 2ϩ signals from the endothelium of the intact vessels, the arteries were denuded of their endothelium (see MATERIALS AND METHODS), loaded with fura 2, and pressurized to 70 mmHg (the standard condition). The vessels were superfused with Krebs solution containing 10 M nifedipine to minimize Ca 2ϩ entry through L-type Ca 2ϩ channels and 5 M guanethidine to deplete sympathetic nerve terminals of catecholamines. Under these conditions, stimulation of the vessels with 5 M of the ␣-adrenergic agonist, PE, for periods of 15-20 min induced Ca 2ϩ transients (increase in the F 360 /F 380 ratio; see MATERIALS AND METH-ODS). These transients were characterized by an early peak with oscillations and a delayed plateau (Fig. 5A) .
The Ca 2ϩ transients were highly reproducible; the peaks and plateaus varied by Ͻ7 and 10%, respectively, in five successive applications of PE under control conditions (n ϭ 5 vessels). Superfusion of the vessels for 30 min with 1-100 nM ouabain in the Krebs solution had no effect on the baseline (resting) [Ca 2ϩ ] cyt (i.e., F 360 /F 380 did not change) but increased both the initial peak of the Ca 2ϩ transient and the subsequent plateau evoked by PE (Fig. 5A) . Figure 5B shows the ouabain dose-response curves for both the peak and the plateau (steady state). The "threshold" ouabain concentrations for amplification of both the peak and the plateau were similar (Ͻ1 nM). The two curves also had comparable EC 50 values (4 and 8 nM) that were also similar to the EC 50 for ouabain in cultured cells (8 nM ; Fig. 1B) . (Fig. 6) , whereas the plateau responses were reversibly abolished. The initial Ca 2ϩ transient is thought to reflect primarily Ca 2ϩ release from the sarcoplasmic reticulum (SR) stores, whereas the plateau is likely the result of Ca 2ϩ entry through activated SOC that can be blocked by 10 mM Mg 2ϩ (2, 52) . Figure 7 shows the effects of [Mg 2ϩ ] O on the ouabain-induced augmentation of the Ca 2ϩ transient evoked by PE in the vessels. Prolonged incubation with 3.3 nM ouabain reversibly augmented the peak Ca 2ϩ transients evoked by PE (Fig. 7A) . When [Mg 2ϩ ] O was increased to 10 mM in the presence of ouabain, the magnitude of the evoked transients was reduced to normal (i.e., to the "control" level observed in the absence of ouabain), and the plateau disappeared (Fig. 7, A and B) . The ability of elevated [Mg 2ϩ ] O to block the amplification of the Ca 2ϩ transients by low-dose ouabain in the arteries resembles the effects observed in the cultured myocytes ( Fig. 4A and Table 1C ). Figure 8 is a model depicting key transport proteins involved in the augmentation of vasotonic effects (48) in the rat inhibit only a small fraction of the Na ϩ pumps of a cell, so that there should be negligible rise in whole cell [Na ϩ ] cyt . Indeed, several investigators have pointed out that the cardiotonic effects of CTS can be observed without any detectable rise in [Na ϩ ] cyt (9, 31) , but their reports have generally been ignored. Our observations are not only consistent with these reports and support the view that the cardiotonic and vasotonic actions of low-dose CTS can occur in the absence of a rise in whole cell [Na ϩ ] cyt but now suggest a plausible mechanism for these effects. Moreover, our results indicate specific and distinct functional roles for the two isoforms of the Na ϩ pump ␣-subunit (␣1 and either ␣2 or ␣3) that are coexpressed but differently distributed in the PL of myocytes from arteries and skeletal muscle (26, 30) and perhaps cardiac muscle (25) . Here, we discuss our findings from this perspective, and we propose a new theory of CTS action that embraces these previously unexplained observations.
Low-dose ouabain augments Ca 2ϩ signaling in arterial myocytes with no elevation of whole cell [Na ϩ ] cyt . In pressurized small mesenteric arteries as well as in cultured myocytes, we found that low concentrations of ouabain (1-30 nM) augmented Ca 2ϩ transients. These same low doses of ouabain also augmented vasoconstrictor responses in small arteries (unpublished data). The augmentation of Ca 2ϩ transients by ouabain depended on extracellular Na ϩ . Similar augmentation was also observed with low-dose digoxin, OLC, and reduced [K ϩ ] O in the cultured cells. Thus it appears that this effect was the result of Na ϩ pump inhibition and the reduction of active Na ϩ extrusion rather than some other effect of the CTS. For example, the effect cannot be attributed to "slip-mode conductance" of Ca 2ϩ through voltage-gated Na ϩ channels (38) because mesenteric arterial myocytes do not express such channels (53) and because augmentation occurred in the absence of extracellular Ca 2ϩ (Fig. 1D) . In rat mesenteric artery, the low doses of ouabain, digoxin, and OLC that we used (Յ100 nM) should inhibit only ␣3 Na ϩ pumps. The ␣2-isoform is not expressed in the arterial myocytes, and the much more prevalent ␣1 isoform (26) has an EC 50 more than 1,000-fold greater than the ouabain concentrations used here (5).
It seems paradoxical that low ouabain concentrations or reduction of (Fig. 3) , even though external Na ϩ was required (Fig. 1E ). Yet, the absence of a detectable rise in whole cell [Na ϩ ] cyt is consistent with two related observations. 1) The ␣3 Na ϩ pumps apparently constitute only a small fraction (perhaps 10% or less) of the total Na ϩ pumps in the arterial myocytes (26) . 2) In the cultured myocytes, the effects of low-dose ouabain and OLC were manifested within 30-120 s (Fig. 1, A-E, and Fig. 2 ). The rapidity of the augmentation with 10-100 nM ouabain could not have been due to elevation of whole cell [Na ϩ ] cyt because even 1 M ouabain caused only a slow rise in bulk [Na ϩ ] cyt (Ͻ0.3 mM/min; Fig. 3A) . ] O also significantly reduced PE-evoked plateau (# P Ͻ 0.05) to a level that was not significantly different from resting F 360 /F 380 ratio (P Ͼ 0.05). All solutions contained 10 M nifedipine and 5 M guanethidine.
A critical observation was that low-dose ouabain amplified Ca 2ϩ signals even in the absence of extracellular Ca 2ϩ (Fig. 1D ). This effect might be explained by reduced Ca 2ϩ extrusion (e.g., via Na/Ca exchange). Consistent with this hypothesis, a 2-min incubation in 0 Ca to Ͻ10 mM) augmented evoked Ca 2ϩ transients in the absence of ouabain (Fig. 1F) . When taken together, the data fit the idea that the augmentation was the result of reduced Ca 2ϩ efflux via Na/Ca exchange, because of either a low [Na ϩ ] O (as in Fig. 1F ) or a high [Na ϩ ] cyt in the vicinity of the Na/Ca exchanger brought about by the inhibition of the ␣3 Na ϩ pumps by the low-dose ouabain (Fig. 1D and see below) . Na ϩ pump catalytic subunit (␣) isoforms: their functional significance. Although Na ϩ pump inhibition may augment Ca 2ϩ signaling by inhibiting, indirectly, Ca 2ϩ extrusion via Na/Ca exchangers, it was necessary to find an explanation for the effect in the absence of elevation of whole cell [Na ϩ ] cyt . Recent observations of differential Na ϩ pump isoform distribution and the localization of Na/Ca exchangers provided important clues that may help to resolve this dilemma. In mesenteric arterial myocytes, both the ␣3 Na ϩ pumps and the Na/Ca exchangers (27) are confined to discrete domains of PL that overlie the jSR (Fig. 8) . In contrast, the low ouabain-affinity ␣1 Na ϩ pumps and the PL (ATP-driven) Ca 2ϩ pumps are distributed uniformly over the remainder of the cell surface (27). Restricted localization of the ␣2-or ␣3-isoforms of the Na ϩ pump along with the Na/Ca exchanger in PL microdomains adjacent to jS/ER, have also been observed in other cell types (21, 27, 30, 36) . Furthermore, transgenic studies reveal that, in mouse cardiac muscle, ␣1 and ␣2 are coexpressed, but the latter selectively mediates the cardiotonic effect of low-dose ouabain (25) . In addition, several groups have reported that the activity of the cardiac Na/Ca exchanger is tightly coupled to the Na ϩ pump through a small compartment of cytosol (presumably sub-PL) that has restricted diffusional access to the bulk cytosol (14, 33, 45 (10, 15, 43, 47) as well as in cardiac myocytes (29, 41) .
We propose that these discrete regions of cytosol are located between the jSR and the overlying PL microdomains that, in arterial smooth muscle cells, contain the Na/Ca exchangers and the ␣3 Na ϩ pumps (Fig. 8) . Indeed, functional evidence indicates that some Ca 2ϩ entry and exit in smooth muscle proceeds through a restricted cytoplasmic compartment, the "superficial buffer barrier" (10, 47) , and that Ca 2ϩ released from the jSR into this junctional space is preferentially extruded via the Na/Ca exchangers without affecting bulk [Ca 2ϩ ] cyt (47) . These functional units may be analogous to the triads and dyads of skeletal and cardiac muscle (13, 20) and have been called "PLasmERosomes" (7) . If the junctional regions are assumed to be disc shaped, with diameters of Ϸ200 nm and PL-jSR separation of Ϸ12 nm (42), a single PLasmERosome should have a volume of Ϸ5 ϫ 10 Ϫ19 l; it should contain only Ϸ2,500-3,000 Na ϩ if the local [Na ϩ ] is comparable with that in bulk cytosol (Ӎ9 mM; Fig. 3 ). concentration. Our results suggest, however, that these events are mediated preferentially by specific transporters located in the PLasmERosomes (Fig. 8) . The increased Ca 2ϩ released at the jSR should then be sufficient to augment whole cell Ca 2ϩ signaling (Fig.  1, A-D nor Mg 2ϩ is thought of as a specific SOC blocker. Nevertheless, the similarity of their effects at the concentrations used and the fact that they did not affect the 5-HT-or PE-evoked Ca 2ϩ transient peaks in the absence of ouabain ( Significantly, comparable effects of low-dose ouabain and of elevated Mg 2ϩ on Ca 2ϩ signaling were observed in small resistance arteries (Figs. 5-7) . Here, the PEevoked Ca 2ϩ transient in the presence of nifedipine consisted of a large rise and oscillation of [Ca 2ϩ ] cyt (Figs. 5A, 6A , and 7A) that may reflect Ca 2ϩ entry through receptor-operated channels (ROC) as well as release of Ca 2ϩ from the SR. This early Ca 2ϩ transient was followed by a decline to a new plateau [Ca 2ϩ ] cyt that was well maintained for at least 20-25 min (Figs. 5A, 6A, 7A) . The plateau probably reflects Ca 2ϩ entry through SOC, and not ROC (4), because it was abolished by 10 mM Mg 2ϩ (Figs. 6 and 7) . In normal medium containing 1.4 mM Mg 2ϩ , low-dose ouabain augmented both the peak and plateau phases of the Ca 2ϩ transient in the isolated arteries (Fig. 5 ). This fits with the idea that ouabain may amplify cell Ca 2ϩ signaling. Elevation of [Mg 2ϩ ] O to 10 mM reduced the peak of the Ca 2ϩ transient augmented by ouabain and completely blocked the augmented plateau phase (Fig.  7) . These results are consistent with the view that both components of the ouabain-induced augmentation of the transient depended on Na ϩ entry through the SOC. (13, 20, 42 ) with a similar complement of PL transport proteins are present. Our results in resistance arteries raise the possibility that local regulation of Na ϩ and Ca 2ϩ may play an important role in the control of vascular tone and blood flow.
Our observations appear to clarify some aspects of the rapid action of therapeutic concentrations of CTS (48) and OLC (Fig. 2) on vascular tissue. The action of OLC itself may provide an additional rationale for the widespread occurrence of discrete receptors for CTS, the affinities of which vary widely (5, 46) . Indeed, a mechanism that can influence, selectively, the responsiveness of many types of cells to a variety of neurohumoral stimuli may have very broad relevance. Furthermore, in addition to ouabain, various agents such as dopamine that modulate Na ϩ pump activity (1, 8) may exert their effects via this mechanism. Finally, elevated plasma levels of OLC are observed frequently in patients with essential hypertension (38) and congestive heart failure (18) . Thus agents that affect the action of ouabain on specific Na ϩ pump isoforms might not only have novel therapeutic consequences (12) but might also provide additional tools with which to explore the effects of local changes in intracellular Na ϩ .
